You just read:

Conatus Pharmaceuticals Initiates Confirmatory Phase 2 Clinical Trial of CTS-1027 for the Treatment of Hepatitis C Virus (HCV)

News provided by

Conatus Pharmaceuticals

Feb 17, 2011, 01:00 ET